Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Boston Scientific Corporation

Boston Scientific Corporation (BSX) Stock Overview

Explore Boston Scientific Corporation’s financial performance, market position, analyst ratings, and future outlook.

BSX●NYSE
HealthcareMedical - Devices
$44.03
$0.59(1.32%)
U.S. Market opens in 6h 20m

Boston Scientific Corporation (BSX)

Meyka AI Score

Z

Key Financials

Market Cap65.4B
P/E Ratio18.31
EPS (TTM)$3.10
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$44.14
3 Months$22.54
1 Year Target$78.34

BSX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Boston Scientific Corporation (BSX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.82, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $78.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.31 and a market capitalization of 65.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.34%
5-Day Change
-3.19%
1-Month Change
-2.07%
3-Month Change
-31.47%
6-Month Change
-50.02%
Year-to-Date (YTD) Change
-53.83%
1-Year Change
-57.94%
3-Year Change
-16.33%
5-Year Change
6.77%
All-Time (Max) Change
928.20%

Contact Information

https://www.bostonscientific.com
508 683 4000
300 Boston Scientific Way, Marlborough, MA, 01752-1234

Company Facts

590,000 Employees
IPO DateMay 19, 1992
CountryUS
Actively Trading

Frequently Asked Questions